Quality managers in pharmaceutical-related industries can now obtain Veriteq's guide to cutting the cost of monitoring critical environments while controlling risk factors.
The free white paper is entitled 'Compliance, risk and cost of ownership comparisons for pharmaceutical continuous monitoring - wired, wireless and standalone monitoring instruments'.
Six different modalities used in pharmaceutical-related industries for continuous monitoring - chart recorders, standalone data loggers, wired LAN networks with UPS backups, wired LAN networks using Power over Ethernet; Wi-Fi and wireless mesh - are systematically explained and compared in terms of lifetime costs of ownership and risks of non-compliance in the context of today's regulatory environment.
Ken Appel, manager of regulated industries for Veriteq, wrote the paper to address the commonly overlooked sources of human error inherent in various monitoring modalities and to provide a systematic way for quality managers to weigh the pros and cons of different approaches to continuous monitoring.
Free copies of this white paper - Compliance, Risk and Cost of Ownership Comparisons for Pharmaceutical Continuous Monitoring-Wired, Wireless and Standalone Monitoring Instruments - can be obtained by writing to ken.appel@vaisala.com
